Reuben Benjamin
Impact in
- Hematology top 1%
- Multiple Myeloma Research and Treatments
- Oncology top 2%
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
Papers in
- Hematology 38
- Multiple Myeloma Research and Treatments 31
- Oncology 40
- CAR-T cell therapy research 23
- Cancer Treatment and Pharmacology 6
- Peptidase Inhibition and Analysis 4
- Co-authors
- Charlotte Graham (5 shared papers)Agnieszka Jóźwik (5 shared papers)Andrea G. S. Pepper (2 shared papers)Stephen Paul Cobbold (1 shared paper)Mike Clark (1 shared paper)Herman Waldmann (1 shared paper)Karl S. Peggs (4 shared papers)Kirsty J. Thomson (4 shared papers)
- Journals
- Blood (13 papers)British Journal of Haematology (8 papers)Leukemia (4 papers)American Journal of Hematology (4 papers)HemaSphere (4 papers)
- Partner nations
- United KingdomUnited StatesGreece
In The Last Decade
Reuben Benjamin
71 papers receiving 3.0k citations
Reuben Benjamin's Hit Papers
Peers
Comparison fields: 5 of 93
- Hematology 938
- Oncology 1.7k
- Immunology 496
- Genetics 188
- Infectious Diseases 310
Countries citing papers authored by Reuben Benjamin
This map shows the geographic impact of Reuben Benjamin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reuben Benjamin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reuben Benjamin more than expected).
Fields of papers citing papers by Reuben Benjamin
This network shows the impact of papers produced by Reuben Benjamin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reuben Benjamin. The network helps show where Reuben Benjamin may publish in the future.
Co-authors
The 25 scholars most cited alongside Reuben Benjamin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 72 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 302 | |
| 2 | Once-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma (BOSTON): a randomised, open-label, phase 3 trial Hit paper breakdown → | 2020 | 252 |
| 3 | Immune effector cell–associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations Hit paper breakdown → | 2023 | 236 |
| 4 | 2018 | 195 | |
| 5 | LocoMMotion: a prospective, non-interventional, multinational study of real-life current standards of care in patients with relapsed and/or refractory multiple myeloma Hit paper breakdown → | 2022 | 191 |
| 6 | 2018 | 149 | |
| 7 | 1986 | 139 | |
| 8 | 2009 | 134 | |
| 9 | 2022 | 117 | |
| 10 | 2020 | 86 | |
| 11 | 2021 | 81 | |
| 12 | 2021 | 81 | |
| 13 | Optimization of methods to achieve mRNA-mediated transfection of tumor cells in vitro and in vivo employing cationic liposome vectors. | 1994 | 75 |
| 14 | 2021 | 60 | |
| 15 | 2015 | 59 | |
| 16 | 2008 | 56 | |
| 17 | 2024 | 47 | |
| 18 | 2005 | 45 | |
| 19 | 2020 | 44 | |
| 20 | 2008 | 43 |
About Reuben Benjamin
Reuben Benjamin is a scholar working on Hematology, Oncology, Genetics, Molecular Biology and Genetics, having authored 72 papers that have together received 3.1k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (31 papers), CAR-T cell therapy research (23 papers), Protein Degradation and Inhibitors (12 papers), Virus-based gene therapy research (9 papers), Cancer Treatment and Pharmacology (6 papers), Chronic Lymphocytic Leukemia Research (6 papers), Advancements in Semiconductor Devices and Circuit Design (4 papers) and Peptidase Inhibition and Analysis (4 papers). The work is most often cited by research in Hematology (938 citations), Oncology (1.7k citations), Immunology (496 citations), Genetics (188 citations) and Infectious Diseases (310 citations). Reuben Benjamin has collaborated with scholars based in United Kingdom, United States and Greece. Frequent co-authors include Charlotte Graham, Agnieszka Jóźwik, Andrea G. S. Pepper, Stephen Paul Cobbold, Mike Clark, Herman Waldmann, Karl S. Peggs, Kirsty J. Thomson, Claire Roddie and DT Curiel. Their work appears in journals such as Blood, British Journal of Haematology, Leukemia, American Journal of Hematology and HemaSphere.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.